What Causes Late-Onset Type 1 Diabetes in Adults?

Late-onset type 1 diabetes in adults results from the same fundamental process as childhood type 1: the immune system attacks and destroys the insulin-producing beta cells of the pancreas. But in adults, this autoimmune destruction tends to unfold far more slowly, sometimes over years or even decades, which is a large part of why so many cases are missed or mislabeled as type 2 diabetes. The triggers and genetic underpinnings overlap with childhood-onset disease but are not identical, and a growing body of research points to environmental factors, immune aging, and even certain cancer medications as contributors.

More Common Than Most People Realize

There is a stubborn myth that type 1 diabetes is a childhood disease. In reality, data from more than 1.3 million U.S. adults show that roughly 37% of people with type 1 diabetes were diagnosed after age 30.¹ Incidence data from 32 countries put the figure even higher, with adults accounting for a median 42% of all new type 1 diabetes diagnoses.² Men and racial or ethnic minorities tend to be diagnosed at later ages than women and non-Hispanic White adults, which further complicates the picture.¹

Because doctors and patients alike associate type 1 with children, adults who develop autoimmune diabetes are frequently told they have type 2. A study from the Diabetes Alliance for Research in England found that about 38% of people diagnosed with type 1 diabetes after age 30 were initially misdiagnosed with type 2 and did not receive insulin when they needed it.³ That delay matters. It raises the risk of diabetic ketoacidosis and forfeits the window during which preserving remaining beta-cell function might still be possible.²

A Slower Autoimmune Attack

In children, the autoimmune destruction of beta cells is often fast and dramatic. Blood sugar spirals upward over weeks, and by the time symptoms are obvious, most of the insulin-producing capacity is already gone. In adults, the same immune process can smolder at a much lower intensity. The slowly evolving form of adult autoimmune diabetes is sometimes called latent autoimmune diabetes of adults, or LADA, and it accounts for an estimated 2 to 12% of all patients with adult-onset diabetes, depending on the population studied.⁴ At diagnosis, these individuals look like type 2 patients because they do not yet need insulin, even though their immune systems are already dismantling the same cells.

The antibody profile of adult-onset disease also differs from childhood-onset. In children, multiple types of autoantibodies against islet cells are common. In adults, the antibody picture is often simpler. Antibodies against an enzyme called GAD (glutamic acid decarboxylase) are by far the most frequent marker of autoimmune diabetes in adults, while insulin autoantibodies, which show up in more than 40% of children with type 1, appear in fewer than 4% of adults.⁵ Adults with autoimmune diabetes are also less likely to carry multiple autoantibody types at once.⁶ This simpler antibody signature is one reason the autoimmune process takes longer to fully destroy the pancreas in adults: the immune assault appears less aggressive from multiple fronts.

That slower pace means adults often retain measurable insulin production for years after diagnosis. C-peptide, a molecule released alongside insulin, serves as a proxy for how much insulin the pancreas still makes. Adults diagnosed with type 1 diabetes frequently have detectable C-peptide levels well beyond the point at which children’s production has dropped to near zero.⁷ This lingering insulin production contributes to better blood-sugar control and is part of why adult-onset cases can go unrecognized for so long.

What Happens Inside the Pancreas

The microscopic hallmark of type 1 diabetes is insulitis, an inflammatory process in which immune cells cluster around and invade the insulin-producing islets. Even at the moment of diagnosis, only a modest fraction of islets show active insulitis at any given time.⁸ The immune cells involved shift with age. In the youngest children, the infiltrates contain abundant killer T-cells alongside B-cells, creating an intense, contact-driven attack on beta cells. The B-cells in these infiltrates appear to help activate T-cells near the islets rather than secreting antibodies themselves, potentially amplifying the damage.⁹

In adults, the inflammatory picture tends to be less intense. There are fewer immune cells per islet, and the process drags on at a lower simmer. This difference in the character and ferocity of the islet inflammation helps explain the slower beta-cell loss and prolonged “honeymoon” period that many adults experience after diagnosis, during which they need relatively little insulin.

Genetic Risk Factors Differ From Childhood Type 1

Both childhood and adult-onset type 1 diabetes share genetic roots in the HLA region, a stretch of DNA that shapes how the immune system distinguishes self from non-self. But the specific risk variants are not the same. In childhood-onset disease, the combination of HLA-DR3 and HLA-DR4 is the classic high-risk genotype. In adults diagnosed after age 35, the DR4-linked gene variant DRB1*04 emerges as a prominent risk factor, with odds ratios suggesting a roughly tenfold increase in risk compared to people without it.¹⁰ Meanwhile, differences in immune-signaling gene variants, including the promoter region of the inflammatory molecule IL-18, distinguish LADA from classic adult-onset type 1, hinting that the slowly evolving form has its own genetic flavor.¹⁰

Genome-wide analyses have also identified novel genetic loci linked to adult type 1 diabetes that were not previously flagged in childhood studies, including variants on chromosomes 6, 12, 14, and 22.¹¹ The overall picture is that adult-onset autoimmune diabetes occupies a partially overlapping but distinct genetic landscape. The predisposition is real and heritable, but the specific combination of risk genes influences both whether the disease appears and when.

Environmental Triggers

Genes load the gun, but environmental factors pull the trigger. Several candidates have been studied extensively, though none has been proven to be a single definitive cause.

Viral Infections

Enteroviruses, a family that includes Coxsackievirus, are the most consistently implicated infectious trigger for type 1 diabetes. A meta-analysis pooling 38 case-control studies found a significant association between enterovirus infection and type 1 diabetes across European, African, Asian, Australian, and Latin American populations.¹² The suspected mechanism involves persistent, low-grade infections in the pancreas that keep the immune system on alert. Recent work has strengthened the link, suggesting that enteroviruses may nudge the autoimmune process forward at multiple stages of disease development, from the initial appearance of autoantibodies to the final loss of beta-cell function.¹³

The Gut Connection

Changes in gut bacteria and the integrity of the intestinal lining have attracted growing attention. The concept, sometimes called “leaky gut,” involves an intestinal barrier that allows molecules and microbial fragments to pass through more readily than normal, potentially provoking immune responses against the body’s own tissues. Evidence from both human studies and animal models supports the idea that increased intestinal permeability is a feature of type 1 diabetes, though whether it is a cause, a consequence, or both remains debated.¹⁴ An imbalance in gut microbial communities appears to worsen this barrier problem and promote the kind of inflammatory environment that could push genetically predisposed individuals toward beta-cell autoimmunity.¹⁵ Gut microbial alterations have also been shown to compromise immune balance more broadly, contributing to the disease process.¹⁶

Psychological Stress

Stress is an underappreciated environmental factor. Evidence suggests that psychological stress can precipitate the onset of type 1 diabetes in genetically predisposed individuals, with immune disruptions detectable before a formal diagnosis.¹⁷ Stress hormones like cortisol are known to affect immune regulation, and chronic stress in particular may tip a borderline autoimmune process from smoldering to active. While the research here is less definitive than for viral triggers, the association is consistent enough to be taken seriously, especially in adults dealing with prolonged life stress.

When Cancer Drugs Trigger Type 1 Diabetes

One of the more dramatic causes of adult-onset type 1 diabetes is immune checkpoint inhibitor therapy, a class of cancer drugs that works by releasing the brakes on the immune system so it can attack tumors. The same unleashed immune response can turn against the pancreas. Cases of checkpoint inhibitor-induced type 1 diabetes have been reported globally, and more than half present as sudden-onset diabetic ketoacidosis, a medical emergency.¹⁸

The risk is not trivial. Among commercially insured U.S. adults taking these drugs, the incidence of new autoimmune diabetes was roughly seven times higher than the background rate of type 1 diabetes in the general adult population.¹⁹ The timing varies widely. In one study, the median time from starting treatment to developing diabetes was about 16 weeks, but some patients did not develop it until more than two years into therapy.²⁰ This form of type 1 diabetes is essentially iatrogenic, meaning it is caused by the treatment itself, and it can appear in people with no prior autoimmune history or family history of diabetes. It underscores just how finely balanced the immune system normally is: removing one checkpoint protein can be enough to tip the entire system toward pancreatic self-destruction.

How Immune Aging Plays a Role

The immune system changes with age in ways that could make late-onset autoimmunity more likely in some people. As immune cells age, they accumulate damage from metabolic stress, chronic exposure to pathogens, and DNA wear. Senescent immune cells, those that are still alive but no longer function normally, tend to pile up over time. These cells undermine the body’s ability to maintain self-tolerance, the process by which the immune system learns not to attack its own tissues. They also weaken the function of regulatory T-cells, the immune cells responsible for keeping autoimmune responses in check, and enhance autoantibody production.²¹

This age-related immune dysfunction could help explain why some people develop autoimmune diabetes at 40, 50, or even 70 despite carrying the genetic risk all their lives. The immune system may have been keeping the autoimmune process suppressed for decades, and the gradual erosion of that suppression through normal aging finally lets the attack proceed. It is a plausible mechanism, though proving it in any individual case remains impossible with current tools.

The Role of Metabolic Stress and Body Weight

An interesting wrinkle in the story involves metabolic stress. Research in children has shown that higher body weight at diagnosis is associated with earlier presentation of type 1 diabetes, suggesting that insulin resistance and the extra metabolic load on beta cells may accelerate the autoimmune process.²² The “accelerator hypothesis” proposes that the same metabolic pressures that drive type 2 diabetes, namely insulin resistance and beta-cell overwork, can speed up beta-cell destruction in people who also have autoimmune disease.

In adults, this metabolic overlap creates a condition sometimes called “double diabetes,” where features of both type 1 (autoimmune destruction) and type 2 (insulin resistance) coexist in the same person.²³ An overweight adult with smoldering autoimmune diabetes may find that their beta cells give out faster than expected because they are simultaneously being attacked by the immune system and overworked by insulin resistance. The clinical challenge is recognizing that both processes are happening at once, since these patients often look like straightforward type 2 cases until their blood sugar becomes unexpectedly difficult to control.

Treatment Considerations Unique to Adult-Onset Cases

The slow-burning nature of adult autoimmune diabetes raises a tricky treatment question: when should insulin start? Because many adults still produce some of their own insulin at diagnosis, they can sometimes manage their blood sugar temporarily with oral medications or lifestyle changes. But not all oral medications are equally safe for these patients. Sulfonylureas, a common type 2 diabetes drug that whips the pancreas into producing more insulin, may actually exhaust beta cells faster and should be avoided. Early insulin therapy appears to achieve better long-term blood sugar control and may help preserve whatever beta-cell function remains.²⁴

That said, a randomized trial comparing early insulin treatment to conventional care in LADA patients found no significant difference in the rate of C-peptide decline over three years, though the insulin-treated group did have better blood sugar levels at the end of the study period.²⁵ The evidence for early insulin “saving” beta cells is therefore more mixed than it is sometimes presented. What is clear is that insulin will eventually be necessary for nearly all adult-onset type 1 patients, and recognizing the autoimmune nature of the disease early enough to plan for that transition is the core clinical priority.

Cardiovascular Risk and How Adult-Onset Type 1 Compares

One common assumption is that because type 1 diabetes involves autoimmunity rather than the metabolic syndrome typical of type 2, its cardiovascular risk profile must be much more favorable. The reality is more nuanced. A large study found that while adults with type 1 diabetes had lower rates of major cardiovascular events than those with type 2, the incidence of cardiovascular death was similar between the two groups.²⁶ Meanwhile, mortality from diabetic coma and ketoacidosis was roughly seven times higher in the type 1 group, reflecting the acute dangers of insulin deficiency and the particular risks of missed or delayed diagnosis.²⁶

For adults diagnosed with type 1 in middle age, this means cardiovascular screening is still important, even if the traditional risk factors like obesity and high cholesterol seem less relevant. Chronic high blood sugar damages blood vessels regardless of the underlying cause, and adults with type 1 who also have metabolic features of the “double diabetes” pattern face compounded risk from both pathways. The reassuring finding is that well-managed blood sugar and early identification of the correct diabetes type both make a measurable difference in long-term outcomes.

1
AJMC. Many Cases of Adult-Onset T1D Are Diagnosed After Age 30, Study Finds
2
Elsevier / Diabetes Research and Clinical Practice. Adult-onset type 1 diabetes: early detection, differential diagnosis, and emerging disease-modifying therapies
3
PubMed Central. Mistaken Identity: Missed Diagnosis of Type 1 Diabetes in an Older Adult
4
Diabetes. Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel
5
PubMed. A comparison of childhood and adult type I diabetes mellitus
6
PubMed. Type 1 Diabetes-related Autoantibodies in Different Forms of Diabetes
7
JCI Insight. High residual C-peptide likely contributes to glycemic control in type 1 diabetes
8
PubMed Central. Insulitis in the pathogenesis of type 1 diabetes
9
European Journal of Endocrinology. Insulitis in human type 1 diabetes: lessons from an enigmatic lesion
10
PubMed Central / Annals of the New York Academy of Sciences. Autoimmune diabetes mellitus with adult onset and type 1 diabetes mellitus in children have different genetic predispositions
11
PubMed Central. Genome-wide association study reveals novel loci for adult type 1 diabetes in a 5-year nested case-control study
12
Frontiers in Endocrinology. Association Between Enterovirus Infection and Type 1 Diabetes Risk: A Meta-Analysis of 38 Case-Control Studies
13
PubMed Central. Enteroviruses and Type 1 Diabetes: Multiple Mechanisms and Factors?
14
PubMed Central. The role for gut permeability in the pathogenesis of type 1 diabetes–a solid or leaky concept?
15
PubMed. Is there a role for gut microbiota in type 1 diabetes pathogenesis?
16
EngMedicine. Targeting the gut microbiota in type 1 diabetes mellitus: Therapeutic potential of probiotics and prebiotics
17
PubMed Central. The Impact of Stress on Autoimmune Disorders: Type 1 Diabetes Mellitus and Systemic Lupus Erythematosus
18
PubMed Central. Immune-Checkpoint Inhibitors-Induced Type 1 Diabetes Mellitus: From Its Molecular Mechanisms to Clinical Practice
19
JAMA Oncology. Identification of Immune Checkpoint Inhibitor–Induced Diabetes
20
Scientific Reports. Clinical characteristics and unique presentations of immune checkpoint inhibitor induced type 1 diabetes in Chinese patients from a single institution
21
Frontiers in Immunology. Immune cell senescence in autoimmunity: implications for disease pathogenesis and therapeutic targeting
22
PubMed. Testing the accelerator hypothesis: the relationship between body mass and age at diagnosis of type 1 diabetes
23
PubMed Central. Double diabetes-when type 1 diabetes meets type 2 diabetes: definition, pathogenesis and recognition
24
PubMed Central. Latent autoimmune diabetes of adults: From oral hypoglycemic agents to early insulin
25
PubMed Central. Insulin intervention in LADA
26
European Heart Journal. Adult-onset type 1 diabetes: predictors of major cardiovascular events and mortality